These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38885189)

  • 1. Effect of Polymer Architecture and Acidic Group Density on the Degree of Salt Formation in Amorphous Solid Dispersions.
    Neusaenger AL; Fatina C; Yu J; Yu L
    Mol Pharm; 2024 Jul; 21(7):3375-3382. PubMed ID: 38885189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amorphous Drug-Polymer Salts: Maximizing Proton Transfer to Enhance Stability and Release.
    Neusaenger AL; Yao X; Yu J; Kim S; Hui HW; Huang L; Que C; Yu L
    Mol Pharm; 2023 Feb; 20(2):1347-1356. PubMed ID: 36668815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers.
    Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
    J Pharm Sci; 2013 Jan; 102(1):171-84. PubMed ID: 23132686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acid-base interactions in amorphous solid dispersions of lumefantrine prepared by spray-drying and hot-melt extrusion using X-ray photoelectron spectroscopy.
    Song Y; Zemlyanov D; Chen X; Su Z; Nie H; Lubach JW; Smith D; Byrn S; Pinal R
    Int J Pharm; 2016 Dec; 514(2):456-464. PubMed ID: 27370910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved Release of Celecoxib from High Drug Loading Amorphous Solid Dispersions Formulated with Polyacrylic Acid and Cellulose Derivatives.
    Xie T; Taylor LS
    Mol Pharm; 2016 Mar; 13(3):873-84. PubMed ID: 26791934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small scale screening to determine the ability of different polymers to inhibit drug crystallization upon rapid solvent evaporation.
    Van Eerdenbrugh B; Taylor LS
    Mol Pharm; 2010 Aug; 7(4):1328-37. PubMed ID: 20536263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical Stability and Dissolution of Lumefantrine Amorphous Solid Dispersions Produced by Spray Anti-Solvent Precipitation.
    Bhujbal SV; Pathak V; Zemlyanov DY; Taylor LS; Zhou QT
    J Pharm Sci; 2021 Jun; 110(6):2423-2431. PubMed ID: 33387599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amorphous Drug-Polymer Salt with High Stability under Tropical Conditions and Fast Dissolution: The Challenging Case of Lumefantrine-PAA.
    Yao X; Kim S; Gui Y; Chen Z; Yu J; Jones KJ; Yu L
    J Pharm Sci; 2021 Nov; 110(11):3670-3677. PubMed ID: 34371071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amorphous Drug-Polymer Salt with High Stability under Tropical Conditions and Fast Dissolution: The Case of Clofazimine and Poly(acrylic acid).
    Gui Y; McCann EC; Yao X; Li Y; Jones KJ; Yu L
    Mol Pharm; 2021 Mar; 18(3):1364-1372. PubMed ID: 33522821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of HPMC based polymers performance as carriers for manufacture of solid dispersions using the melt extruder.
    Ghosh I; Snyder J; Vippagunta R; Alvine M; Vakil R; Tong WQ; Vippagunta S
    Int J Pharm; 2011 Oct; 419(1-2):12-9. PubMed ID: 21782911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amorphous Polymeric Drug Salts as Ionic Solid Dispersion Forms of Ciprofloxacin.
    Mesallati H; Umerska A; Paluch KJ; Tajber L
    Mol Pharm; 2017 Jul; 14(7):2209-2223. PubMed ID: 28570079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of drug-excipient interactions in lapatinib amorphous solid dispersions using solid-state NMR spectroscopy.
    Song Y; Yang X; Chen X; Nie H; Byrn S; Lubach JW
    Mol Pharm; 2015 Mar; 12(3):857-66. PubMed ID: 25585133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of hypromellose acetate succinate (HPMCAS) as a carrier in solid dispersions.
    Tanno F; Nishiyama Y; Kokubo H; Obara S
    Drug Dev Ind Pharm; 2004 Jan; 30(1):9-17. PubMed ID: 15000425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of polymer type and storage relative humidity on the kinetics of felodipine crystallization from amorphous solid dispersions.
    Rumondor AC; Stanford LA; Taylor LS
    Pharm Res; 2009 Dec; 26(12):2599-606. PubMed ID: 19806435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of Polymers with Enzalutamide Nanodroplets-Impact on Droplet Properties and Induction Times.
    Wilson VR; Mugheirbi NA; Mosquera-Giraldo LI; Deac A; Moseson DE; Smith DT; Novo DC; Borca CH; Slipchenko LV; Edgar KJ; Taylor LS
    Mol Pharm; 2021 Mar; 18(3):836-849. PubMed ID: 33539105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation into Intermolecular Interactions and Phase Behavior of Binary and Ternary Amorphous Solid Dispersions of Ketoconazole.
    Sarpal K; Tower CW; Munson EJ
    Mol Pharm; 2020 Mar; 17(3):787-801. PubMed ID: 31860316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions.
    Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
    J Pharm Pharmacol; 2014 Feb; 66(2):244-55. PubMed ID: 24433425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypromellose acetate succinate based amorphous solid dispersions via hot melt extrusion: Effect of drug physicochemical properties.
    Sarabu S; Kallakunta VR; Bandari S; Batra A; Bi V; Durig T; Zhang F; Repka MA
    Carbohydr Polym; 2020 Apr; 233():115828. PubMed ID: 32059882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Balancing Solid-State Stability and Dissolution Performance of Lumefantrine Amorphous Solid Dispersions: The Role of Polymer Choice and Drug-Polymer Interactions.
    Hiew TN; Zemlyanov DY; Taylor LS
    Mol Pharm; 2022 Feb; 19(2):392-413. PubMed ID: 34494842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type.
    Jackson MJ; Kestur US; Hussain MA; Taylor LS
    Mol Pharm; 2016 Jan; 13(1):223-31. PubMed ID: 26618718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.